These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10064014)

  • 21. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second-dose thrombolytic following myocardial infarction.
    Furniss SS; Millar RN; Commerford PJ
    S Afr Med J; 1997 Feb; 87(2):179, 182. PubMed ID: 9107231
    [No Abstract]   [Full Text] [Related]  

  • 23. Thrombolytic therapy for myocardial infarction.
    Brophy J
    N Engl J Med; 1998 Feb; 338(8):545-6; author reply 546-7. PubMed ID: 9471557
    [No Abstract]   [Full Text] [Related]  

  • 24. Third generation plasminogen activators in the treatment of acute myocardial infarction.
    Talley JD
    J Ark Med Soc; 1996 Apr; 92(11):587-8. PubMed ID: 8675487
    [No Abstract]   [Full Text] [Related]  

  • 25. Thrombolytic therapy for myocardial infarction.
    Frei S
    N Engl J Med; 1998 Feb; 338(8):545; author reply 546-7. PubMed ID: 9471556
    [No Abstract]   [Full Text] [Related]  

  • 26. Controlled trials comparing reteplase with alteplase and streptokinase in patients with acute myocardial infarction.
    Amsterdam EA
    Pharmacotherapy; 1996; 16(5 Pt 2):137S-140S. PubMed ID: 8888101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombolytic therapy in acute myocardial infarct].
    Bode C; Baumann H; von Hodenberg E; Kübler W
    Med Klin (Munich); 1992 Feb; 87(2):64-9. PubMed ID: 1542285
    [No Abstract]   [Full Text] [Related]  

  • 28. What do new lytics add to t-PA?
    Van de Werf F
    Am Heart J; 1999 Aug; 138(2 Pt 2):S115-20. PubMed ID: 10426869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reteplase (Retavase).
    Med Lett Drugs Ther; 1997 Feb; 39(995):17-8. PubMed ID: 9057777
    [No Abstract]   [Full Text] [Related]  

  • 30. [New thrombolytic agents in myocardial infarction].
    Helft G; Elalamy I; Beygui F; Dambrin G; Lecompte T; Le Pailleur C; Le Feuvre C; Metzger JP; Vacheron A; Samama MM
    Arch Mal Coeur Vaiss; 1999 Apr; 92(4):411-7. PubMed ID: 10326149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of thrombolytic therapy on platelet expression and plasma concentration of PECAM-1 (CD31) in patients with acute myocardial infarction.
    Serebruany VL; Gurbel PA
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):153-8. PubMed ID: 9888878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New clot busters threaten Genentech's tPA.
    Davidson S
    Nat Biotechnol; 1997 May; 15(5):405. PubMed ID: 9131608
    [No Abstract]   [Full Text] [Related]  

  • 35. Tissue plasminogen activator: from molecular biology to myocardial infarction.
    Chien KR; Meidell R; Gerard R
    Am J Med Sci; 1987 Mar; 293(3):201-7. PubMed ID: 3105313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence.
    Topol EJ
    Circulation; 1998 Jan; 97(2):211-8. PubMed ID: 9445175
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibody-targeted thrombolytic agents.
    Haber E; Quertermous T; Matsueda GR; Runge MS; Bode C
    Jpn Circ J; 1990 Apr; 54(4):345-53. PubMed ID: 2204740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GPIIb/IIIa polymorphism in patients with myocardial infarction.
    Auguadro C; Mortara A; Priori SG; Specchia G
    Acta Cardiol; 2002 Feb; 57(1):32-3. PubMed ID: 11918133
    [No Abstract]   [Full Text] [Related]  

  • 39. Fibrinogen receptor antagonists: design and clinical applications.
    Eldred CD; Judkins BD
    Prog Med Chem; 1999; 36():29-90. PubMed ID: 10818671
    [No Abstract]   [Full Text] [Related]  

  • 40. Platelet glycoprotein IIIa PlA polymorphism in young men with myocardial infarction.
    Carter AM; Ossei-Gerning N; Grant PJ
    Lancet; 1996 Aug; 348(9025):485-6. PubMed ID: 8709822
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.